NEW AMSTERDAM PARTNERS LLC/NY - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
NEW AMSTERDAM PARTNERS LLC/NY ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2014$4,115,000
-88.2%
106,698
-88.1%
0.28%
-87.9%
Q2 2014$34,887,000
+13.8%
896,379
-0.0%
2.27%
+8.2%
Q1 2014$30,657,000
+43.7%
896,677
-11.8%
2.10%
+48.6%
Q4 2013$21,327,000
-53.7%
1,016,524
-48.1%
1.41%
-8.1%
Q3 2013$46,022,000
+110.8%
1,958,356
+141.0%
1.54%
+32.0%
Q2 2013$21,836,000812,6561.16%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 6,459,139$278,776,0005.53%
Tieton Capital Management, LLC 119,290$5,149,0004.04%
RPg Family Wealth Advisory, LLC 97,202$4,195,238,0003.85%
RK Capital 384,900$16,612,0002.90%
Contrarius Investment Management Ltd 652,288$28,153,0002.65%
S&T BANK/PA 331,885$14,324,0002.22%
Euclidean Technologies Management, LLC 40,917$1,766,0001.90%
AIMZ Investment Advisors, LLC 45,635$1,970,0001.80%
Taylor Frigon Capital Management LLC 34,783$1,486,0001.67%
KILLEN GROUP INC 366,305$15,810,0001.63%
View complete list of MYRIAD GENETICS INC shareholders